Bachmann-M B, Biscoping J, Adams H A, Menges T, Krumholz W, Hempelmann G
Abteilung für Anaesthesiologie und Operative Intensivmedizin, Klinikum der Justus-Liebig-Universität Giessen.
Reg Anaesth. 1990 Jan;13(1):16-20.
Knowledge of the actual concentrations of local anesthetic administered by various techniques is essential requisite when undesirable side effects and possible toxicity of a substance are to be evaluated. Therefore, numerous studies of plasma concentrations have been presented, which were carried out with the additional purpose of analyzing the kinetics of different local anesthetics with respect to limiting-value concentrations in the organism. Despite a sufficient degree of precision in the analysis of amide local anesthetics, it is uncertain whether the results of the different studies are comparable, because blood samples have been taken variously from peripheral veins, central veins or arteries. In the present study changes in bupivacaine concentrations were monitored by means of a standardized method consisting in simultaneous sampling of blood in peripheral veins, central veins and arteries. METHODS. Each of 12 patients undergoing orthopedic hip surgery received average 17 ml bupivacaine (0.75%) via peridural lumbar catheter. After the administration of bupivacaine, blood samples were taken simultaneously from peripheral veins, central veins and arteries at 1, 3, 5, 10, 15, 30, 45, 60, and 90 min after injection. Placement of an arterial cannula and central venous catheter was indicated in all patients (hip-joint revision arthroplasty). Quantitative analysis of bupivacaine concentration was carried out by means of high-pressure liquid chromatography (HPLC). All patients had given their informed consent. RESULTS. All patients showed a rapid increase in bupivacaine concentration in the central venous blood within the first few minutes after administration, the maximum being reached between 3 and 10 min after. A similar course was observed with arterial plasma concentrations; absolute values, however, were an average of 10-20% lower at 15 min following administration. Bupivacaine concentrations in peripheral veins rose more slowly and reached a maximum between 15 and 30 min. At 30 min after peridural application the concentration curves in blood from all three sites were similar. DISCUSSION. In earlier studies the influence of the site of blood sampling has often been underestimated. According to our results, central venous and arterial plasma concentrations correspond closely at all times following peridural application. The observed uniform differences in concentrations at the various sites of sampling can be explained by the fact that pulmonary uptake of local anesthetics causes the lower arterial levels. Especially in the early phase of resorption after administration of local anesthetics, the concentration in peripheral blood does not seem to be representative, because an equilibrium is not established between arterial and central venous blood until 30 min after administration at the earliest. In our opinion the peripheral venous concentrations are unreliable, particularly in the early phases, for the evaluation of unwanted effects or toxicity of local anesthetics, because the initial low values and the delayed increase in these could lead to a false sense of security.
当要评估一种物质的不良副作用和可能的毒性时,了解通过各种技术给予的局部麻醉剂的实际浓度是必不可少的前提条件。因此,已经有许多关于血浆浓度的研究,这些研究还额外带有分析不同局部麻醉剂在机体中的极限浓度方面的动力学的目的。尽管在酰胺类局部麻醉剂的分析中具有足够的精度,但不同研究的结果是否具有可比性尚不确定,因为血样是从外周静脉、中心静脉或动脉中以不同方式采集的。在本研究中,通过一种标准化方法监测布比卡因浓度的变化,该方法包括同时在外周静脉、中心静脉和动脉中采集血样。方法。12例接受骨科髋关节手术的患者,平均通过硬膜外腰椎导管接受了17毫升布比卡因(0.75%)。给予布比卡因后,在注射后1、3、5、10、15、30、45、60和90分钟同时从外周静脉、中心静脉和动脉采集血样。所有患者(髋关节翻修置换术)均需放置动脉插管和中心静脉导管。通过高压液相色谱法(HPLC)对布比卡因浓度进行定量分析。所有患者均已签署知情同意书。结果。所有患者在给药后的最初几分钟内,中心静脉血中的布比卡因浓度迅速升高,在给药后3至10分钟达到最大值。动脉血浆浓度也观察到类似的变化过程;然而,给药后15分钟时的绝对值平均低10 - 20%。外周静脉中的布比卡因浓度上升较慢,在15至30分钟之间达到最大值。硬膜外给药后30分钟时,来自所有三个部位的血液中的浓度曲线相似。讨论。在早期研究中,血样采集部位的影响常常被低估。根据我们的结果,硬膜外给药后,中心静脉和动脉血浆浓度在所有时间都紧密对应。在各个采样部位观察到的浓度差异一致,可以解释为局部麻醉剂的肺摄取导致动脉水平较低。特别是在局部麻醉剂给药后的吸收早期,外周血中的浓度似乎不具有代表性,因为最早在给药后30分钟动脉血和中心静脉血之间才建立平衡。我们认为,外周静脉浓度对于评估局部麻醉剂的不良影响或毒性不可靠,特别是在早期阶段,因为其初始低值和随后的延迟升高可能会导致一种虚假的安全感。